TAKEDA PHARMACEUTICAL CO LTD reported 2 transactions at OVID THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/6/2022ACC: 0001395064-22-000121
10% Owner
Since Feb 2019
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
5.75M acquired · 5.75M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−5.75M
Price / share
—
Trade value
—
% of position
New position
7/1/2022
5.75M→0.00
Common Stock
Indirect
Shares
+5.75M
Price / share
—
Trade value
—
% of position
New position
7/1/2022
0.00→5.75M
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/1/2022 | J · J | −5.75M | — | — | New position | 5.75M | 0.00 |
| Common Stock Indirect | 7/1/2022 | J · J | +5.75M | — | — | New position | 0.00 | 5.75M |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions2
Series A Convertible Preferred Stock
Indirect
Converts to
Common Stock
1.25M shares
Shares
−1.25K
Strike price
0.0
Held after
0.00
Exercisable
—
7/1/2022
Series A Convertible Preferred Stock
Indirect
Converts to
Common Stock
1.25M shares
Shares
+1.25K
Strike price
0.0
Held after
1.25K
Exercisable
—
7/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock Indirect | Common Stock1.25M shares | 7/1/2022 | J · J | −1.25K | 0.0 | — | 0.00 |
| Series A Convertible Preferred Stock Indirect | Common Stock1.25M shares | 7/1/2022 | J · J | +1.25K | 0.0 | — | 1.25K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned1.78M
Total
1.78M direct1.78M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.78M | Direct |
| Total | 1.78M | 1.78M direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported